Back to Agenda
Session 2
Session Chair(s)
Masakazu Hirata, MD, PhD
Clinical Reviewer, Division of RS Consultation, Kansai Branch
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Toshiko Ishibashi, PhD, RN
Oncology Medical Science Department, Medical Affairs Division
Daiichi Sankyo Co., Ltd., Japan
Speaker(s)
Session 2 - Presentation 1
Eri Sekine
CMIC Group, Japan
Executive Vice President
Session 2 - Presentation 2
Yuji Kumagai, MD, PhD
Kitasato University Hospital, Japan
Professor, Kitasato Clinical Research Center
Session 2 - Presentation 3
Yusuke Myobatake, MS
Daiichi Sankyo Company, Limited, Japan
Clinical Study Associate, Oncology Clinical Development
Session 2 - Presentation 4
Soyoku Nobeyama, MSc
Janssen Clinical Innovation, United States
Clinical Innovation Leader
Have an account?